Share
Other content recommended for you
- Value assessment frameworks: who is valuing the care in healthcare?
- Audit of data redaction practices in NICE technology appraisals from 1999 to 2019
- National Institute for Health and Clinical Excellence appraisal and ageism
- Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting
- NICE is dead; long live NICE
- NICE and neurology
- Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006
- Justice and the NICE approach
- Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance
- Diagnosis and management of the epilepsies in children: a summary of the partial update of the 2012 NICE epilepsy guideline